BIIB - Biogen Eisai And Eli Lilly: The Potential Pitfalls Of Anti-Amyloid Antibody Drugs
2024-01-30 16:23:19 ET
Summary
- Anti-amyloid drugs likely have little effect on non-APOE4 carriers.
- Anti-amyloid antibody drugs may have an effect on APOE4 carriers, but with serious and potentially fatal side effects.
- Safety issues, including potential adverse brain events, may impact the sales and rollout of these drugs.
...
Biogen, Eisai, And Eli Lilly: The Potential Pitfalls Of Anti-Amyloid Antibody Drugs